Low-level expression and limited role for the inducible isoform of nitric oxide synthase in the vascular hyporeactivity and mortality associated with cecal ligation and puncture in the rat

Shock

Volumn 6, Issue 4, 1996, Pages 248-253

  Vromen, Amos ^a   Arkovitz, Marc S ^a   Zingarelli, Basilia ^a   Salzman, Andrew L ^a   Garcia, Victor F ^a   Szabó, Csaba ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 MERCAPTOETHYL)GUANIDINE; 2-MERCAPTOETHYLGUANIDINE; ENZYME INHIBITOR; GUANIDINE DERIVATIVE; ISOENZYME; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NORADRENALIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CECUM; DRUG ANTAGONISM; DRUG EFFECT; LIGATION; MALE; MORTALITY; PATHOLOGY; PHYSIOLOGY; PUNCTURE; RAT; SEPTIC SHOCK; SPRAGUE DAWLEY RAT; THORACIC AORTA; TIME; VASCULAR RESISTANCE;

ANIMALS; AORTA, THORACIC; CECUM; ENZYME INHIBITORS; GUANIDINES; ISOENZYMES; LIGATION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; PUNCTURES; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, SEPTIC; TIME FACTORS; VASCULAR RESISTANCE;

EID: 0030254769     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199610000-00004     Document Type: Article

References (43)

1. Szabó C: Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 3:2-32, 1995.
2. Szabó C, Thiemermann C: Invited opinion: Role of nitric oxide in haernorrhagic, traumatic and anaphylactic shock and in thermal injury. Shock 2:145-155, 1994.
3. Szabó C, Southan GJ, Thiemermann C: Beneficial effects and improved survival in rodent models of septic shock with S-methyl-isothiourea sulfate, a novel, potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91:12472-12476, 1994.
4. Wu CC, Chen SJ, Szabó C, Thiemermann C, Vane JR: Aminoguanidine inhibits the delayed circulatory failure in endotoxic and haemorrhagic shock in the anaesthetized rat. Br J Pharmacol 114:1666-1672, 1995.
5. Thiemermann C, Rütten H, Wu CC, Vane JR: The multiple organ dysfunction syndrome caused by endotoxin in the rat: Attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 116: 2845-2851, 1995.
6. Szabó C, Bryk R, Zingarelli B, et al: Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform. Br J. Pharmacol 118: 1659-1668, 1996.
7. MacMicking JD, Nathan C, Hom G, et al: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650, 1995.
8. Wei XQ, Charles IG, Smith A, et al: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411, 1995.
9. Laubach VE, Shesely EG, Smithies O, Sherman PA: Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92:10688-10692, 1995.
10. Gross SS, Kilbourn RG, Griffith OW: NO in septic shock: Good, bad or ugly? Lessons from iNOS knock-outs. Trends Microbiol Sci. In press.
11. Cobb JP, Danner RL: Nitric oxide and septic shock. JAMA 275:1192-1196, 1996.
12. Schlag G, Redl H (eds): Pathophysiology of Shock, Sepsis, Organ Failure. Berlin: Springer-Verlag, 1993.
13. Southan GJ, Zingarelli B, O'Connor M, Salzman AL, Szabó C: Spontaneous rearrangement of aminoalkylguanidines into mercaptoalkylguanidines - A novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform. Br J Pharmacol 117:619-632, 1996.
14. Wichteman KA, Baue AE, Chaudry IH: Sepsis and septic shock - A review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
15. Zingarelli B, Salzman, AL, Szabó C: Protective effects of nicotinamide against nitric oxide-mediated vascular failure in endotoxic shock: Potential involvement of polyADP ribosyl synthetase. Shock 5:258-264, 1996.
16. Szabó C: The role of peroxynitrite in the pathophysiology of shock, inflammation and ischemia-reperfusion injury. Shock. In press.
17. Southan GJ, Szabó C: Commentary: Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 51:383-394, 1996.
18. Statman R, Cheng W, Cunningham JN: Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenation. J Surg Res 57:93-98, 1994.
19. Fukahatsu K, Saito H, Fukushima R: Detrimental effects of a nitric oxide synthase inhibitor (Nw-nitro-L-arginine methyl ester) in a murine sepsis model. Arch Surg 130:410-414, 1995.
20. Minnard EA, Shou J, Naama H: Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 129:142-148, 1994.
21. Ruettem H, Southan GJ, Abate AA, Thiemermann C: Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br J Pharmacol 117:261-270, 1996.
22. Laszlo F, Boughton-Smith N, Whittle BJR, et al: Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br J Pharmacol 111:1309-1315, 1994.
23. G-monomethyl-L-arginine HCl improves survival in a conscious instrumented mouse model of endotoxin shock. Endothelium 3:S116, 1995.
24. Wurster SH, Wang P, Dean RE, Chaudry IH: Vascular smooth muscle contractile function is impaired during early and late stages of sepsis. J Surg Res 56:556-561, 1994.
25. Wang P, Ba ZF, Chaudry IH: Nitric oxide: To block or enhance its production during sepsis? Arch Surg 129:1137-1142, 1994.
26. Chen SJ, Wu CC, Yen MH: Alterations of ex vivo vascular reactivity in intraperitoneal sepsis. J Cardiovasc Pharmacol 24:786-793, 1994.
27. Hollenberg SM, Cunnion RE, Zimmerberg J: Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 264:H660-H663, 1993.
28. Heesen BJ, Hotchkiss RS, Karl IE: Sepsis decreases phenylephrine- and KCl-induced aortic ring contraction and decreases the frequency of oscillations in active wall tension. Shock 2:106-112, 1994.
29. Martin CM, Sibbald WJ: Modulation of hemodynamics and organ blood flow by nitric oxide synthase inhibition is not altered in normotensive, septic rats. Am J Resp Crit Care Med 150:1539-1544, 1994.
30. Fox GA, Paterson NA, McCormack DG: Effect of inhibition of NO synthase on vascular reactivity in a rat model of hyperdynamic sepsis. Am J Physiol 267:H1377-H1382, 1994.
31. Li S, Sharon XF, McKenna TM: Role of nitric oxide in sepsis-induced hyporeactivity in isolated rat lungs. Shock 5:122-129, 1995.
32. Aranow JS, Zhuang J, Wang H, Larkin V, Smith M, Fink MP: A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitos: Comparison with two nonselective strategies. Shock 5:116-121, 1996.
33. Southan GJ, Szabó C: Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 51:383-394, 1996.
34. Zhang P, Xie M, Spitzer JA: Hepatic neutrophil sequestration in early sepsis: Enhanced expression of adhesion molecules and phagocytic acti-ity. Shock 2:133-140, 1994.
35. Murata A, Toda H, Uda K, et al: Protective effect of recombinant neutrophil elastase inhibitor (R-020) on sepsis-induced organ injury in rat. Inflammation 18:337-347, 1994.
36. Yang S, Hauptman JG: The efficacy of heparin and antithrombin III in fluid-resuscitated cecal ligation and puncture. Shock 2:433-437, 1994.
37. Schneidkraut MJ, Carlson RW: Cecal ligation and puncture is associated with pulmonary injury in the rat: Role of cyclooxygenase pathway products. Prostaglandins 45:323-334, 1993.
38. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH: Polymicrobial sepsis but not low-dose endotoxin infusion causes decreased splenocyte IL-2/IFN-gamma release while increasing IL-4/IL-10 production. J Surg Res 56:579-585, 1994.
39. Ayala A, Deol ZK, Lehman DL, Herdon CD, Chaudry IH: Does endotoxin play a major role in inducing the depression of macrophage function during polymicrobial sepsis? Arch Surg 130:1178-1184, 1995.
40. O'Reilly M, Silver GM, Davis JH, Gamelli RL, Hebert JC: Interleukin 1 beta improves survival following cecal ligation and puncture. J Surg Res 52:518-522, 1992.
41. Alexander HR, Doherty GM, Venzon DJ, Merino MJ, Fraker DL, Norton JA: Recombinant interleukin-1 receptor antagonist (IL-1ra): Effective therapy against Gram-negative sepsis in rats. Surgery 112:188-193, 1992.
42. Echtenacher B, Falk W, Mannel DN, Krammer PH: Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis. J Immunol 145:3762-3766, 1990.
43. Evans GF, Snyder YM, Butler LD, Zuckerman SH: Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models. Circ Shock 29:279-290, 1989.